{
  "docId": "019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "docSlug": "bb36c74f657a",
  "documentTitle": "Pulse Biosciences (PLSE)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-03 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 4,
  "pageCount": 13,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "table_of_contents",
  "function": "front_matter",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-cb61f3b5c0ba/4",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.03,
        "x": 0.93,
        "y": 0.23
      },
      "kind": "list",
      "text": "01\n01\n02\n05\n07\n08\n08\n10\n10\n11\n12",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "268dca3a-8c8a-437a-90da-c0dc39d28711",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.8,
        "x": 0.07,
        "y": 0.18
      },
      "kind": "list",
      "text": "An Industry Expert’s Analysis of Pulse Biosciences Suggests That Its Pivot Into Benign Thyroid Ablation Will Be Another Dead End\nPulse Biosciences History Of Failure Will Likely Continue\nPulse Biosciences Competitor Kardium Recently Announced Stellar Results for Its PFA Catheter\nDr. Vivek Reddy, Pulse’s Own Hired Consultant, States There Isn’t An Advantage To Using Nano-second PFA Compared to Micro-Second PFA For Most Procedures\nFarapulse Has Already Studied Nano-Pulse Technology for Pulsed Field Ablation Years Before Pulse Biosciences Did\nA Look At Pulse Biosciences Tough Competition in the Pulsed Field Ablation Space\nA Look At The Benign Thyroid Ablation Field\nPulse’s Early Clinical Results For Thryoid Ablation Are Weak\nThe Benign Thryoid Ablation Market Is Small\nPulse Has Lost 3 CEOs Over the Past 3 Years, And Hasn’t Explained The Reasons Why\nConclusion",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b27d622c-cfe9-4eef-afde-4a2d91ed0dcf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.07,
        "y": 0.08
      },
      "kind": "title",
      "text": "Tables of contents",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe74567c-99f5-42ed-b66c-162495ab3a3b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 2,
      "beatId": "fcde8679-d26a-45e2-ad0b-301ddbdb4ca3",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The document presents contradictory information about Pulse Biosciences, such as its competitor Kardium's success and Dr. Vivek Reddy's statement about the advantage of nano-second PFA.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 2,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "1071288f-f643-4626-b233-d55a73d5a78a",
      "evidence": "The document presents a pattern of Pulse Biosciences' failure and weakness, including its history of failure and weak clinical results.",
      "position": 0,
      "objective": "To identify patterns in Pulse Biosciences' failure and weakness",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}